Patients News | pharmaphorum

News

AstraZeneca, MSD raise prostate cancer awareness with 'Never...

A new global prostate cancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co.

News

New HHS rule would harmonise substance abuse privacy rule, H...

The US Department of Health and Human Services issued a new proposed rule Monday that would change how privacy protections for people with substance abuse disorders interact with HIPAA info

News

Genomic testing 'should be offered to all cancer patients in...

A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targ

News

Opdivo backed by NICE for rare gastro-oesophageal cancers

Bristol-Myers Squibb's Opdivo has been recommended as a treatment for around 3,000 people with rare forms of gastro-oesophageal cancer via the NHS in England and Wales.

News

Swing's digital therapy for fibromyalgia hits the right beat

Patients with fibromyalgia – a common condition causing chronic pain, fatigue, poor sleep, and cognitive dysfunction – could get relief from a digital therapeutic (DTx) based on cognitive b

News

NICE rejects five COVID drugs and backs three on price, effi...

NICE has recommended that three COVID-19 therapies can continue to be used to treat patients – Pfizer's Paxlovid, Roche's RoActemra, and Eli Lilly's Olumiant – but turned down another five

AstraZeneca, MSD raise prostate cancer awareness with 'Never...

New HHS rule would harmonise substance abuse privacy rule, H...

Genomic testing 'should be offered to all cancer patients in...

Opdivo backed by NICE for rare gastro-oesophageal cancers

Swing's digital therapy for fibromyalgia hits the right beat

NICE rejects five COVID drugs and backs three on price, effi...

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks